Literature DB >> 15272135

A critical role for MAP kinases in the control of Ah receptor complex activity.

Zongqing Tan1, Mingya Huang, Alvaro Puga, Ying Xia.   

Abstract

The heterodimeric complex of aromatic hydrocarbon receptor (AHR) and Ah receptor nuclear translocator (ARNT) plays a pivotal role in controlling the expression of drug metabolism genes, such as the cytochromes p450 (Cyp) 1a1 and 1b1, believed to be responsible for most toxic effects of the environmental contaminant 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). In this study, we show that activation of Jun N-terminal kinase (JNK) and extracellular signal-regulated kinase (ERK) modulates ARNT transcription activity and potentiates the transcriptional activity of AHR/ARNT complexes. Inhibition of ERK by chemical compounds and ablation of JNK caused significant decreases in CYP1A1 induction by TCDD. Compared to wild type, JNK2 ablation significantly reduced TCDD-stimulated CYP1A1 expression in mouse thymus and testis, but not in liver. In contrast, CYP1B1 expression was unaffected in all three tissues of the knockout mice. These data suggest that JNK and ERK modulate ARNT activity and AHR/ARNT-dependent gene expression, contributing to the gene-specific and tissue-specific toxicity of environmental contaminants.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15272135     DOI: 10.1093/toxsci/kfh228

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  21 in total

Review 1.  P450 monooxygenases (P450ome) of the model white rot fungus Phanerochaete chrysosporium.

Authors:  Khajamohiddin Syed; Jagjit S Yadav
Journal:  Crit Rev Microbiol       Date:  2012-05-25       Impact factor: 7.624

2.  Genome-wide RNAi high-throughput screen identifies proteins necessary for the AHR-dependent induction of CYP1A1 by 2,3,7,8-tetrachlorodibenzo-p-dioxin.

Authors:  Parrisa Solaimani; Robert Damoiseaux; Oliver Hankinson
Journal:  Toxicol Sci       Date:  2013-08-31       Impact factor: 4.849

3.  2,3,7,8-Tetrachlorodibenzo-p-dioxin differentially suppresses angiogenic responses in human placental vein and artery endothelial cells.

Authors:  Yan Li; Kai Wang; Qing-Yun Zou; Ronald R Magness; Jing Zheng
Journal:  Toxicology       Date:  2015-08-11       Impact factor: 4.221

4.  Role of high-fat diet in regulation of gene expression of drug metabolizing enzymes and transporters.

Authors:  Romi Ghose; Ozozoma Omoluabi; Adarsh Gandhi; Pranav Shah; Kelley Strohacker; Katie C Carpenter; Brian McFarlin; Tao Guo
Journal:  Life Sci       Date:  2011-05-18       Impact factor: 5.037

5.  2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) inhibits human ovarian cancer cell proliferation.

Authors:  Yan Li; Kai Wang; Yi-Zhou Jiang; Xin-Wen Chang; Cai-Feng Dai; Jing Zheng
Journal:  Cell Oncol (Dordr)       Date:  2014-11-18       Impact factor: 6.730

6.  An endogenous aryl hydrocarbon receptor ligand inhibits proliferation and migration of human ovarian cancer cells.

Authors:  Kai Wang; Yan Li; Yi-Zhou Jiang; Cai-Feng Dai; Manish S Patankar; Jia-Sheng Song; Jing Zheng
Journal:  Cancer Lett       Date:  2013-07-09       Impact factor: 8.679

Review 7.  The aryl hydrocarbon receptor cross-talks with multiple signal transduction pathways.

Authors:  Alvaro Puga; Ci Ma; Jennifer L Marlowe
Journal:  Biochem Pharmacol       Date:  2008-09-05       Impact factor: 5.858

8.  Dioxin increases the interaction between aryl hydrocarbon receptor and estrogen receptor alpha at human promoters.

Authors:  Shaimaa Ahmed; Eivind Valen; Albin Sandelin; Jason Matthews
Journal:  Toxicol Sci       Date:  2009-07-02       Impact factor: 4.849

9.  Testosterone-dependent interaction between androgen receptor and aryl hydrocarbon receptor induces liver receptor homolog 1 expression in rat granulosa cells.

Authors:  Yanguang Wu; Sarah C Baumgarten; Ping Zhou; Carlos Stocco
Journal:  Mol Cell Biol       Date:  2013-05-20       Impact factor: 4.272

Review 10.  Cytochrome P450 CYP1A1: wider roles in cancer progression and prevention.

Authors:  Vasilis P Androutsopoulos; Aristidis M Tsatsakis; Demetrios A Spandidos
Journal:  BMC Cancer       Date:  2009-06-16       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.